The Production Linked Incentive (PLI) schemes implemented by the Department of Pharmaceuticals have led to avoidance of ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

In return, each drugmaker will receive a three-year exemption from import tariffs on pharmaceutical ingredients, contingent upon expanding their domestic manufacturing operations. In this regard, the ...

President of the General Authority for Investment and Free Zones (GAFI) Hossam Heiba explains the measures being taken to ...

Q3 2025 Revenue Guidance -- Expected between $74.5 million and $75.5 million. Q3 2025 Non-GAAP Operating Expenses Guidance -- Estimated at $51.5 million to $52.5 million. Q3 2025 Non-GAAP EPS Guidance ...

Overview: Explains why generative AI needs a new approach to software testingLists top tools transforming QA automation and evaluationExamines how QA roles and ...

PharmEasy, one of India’s leading healthcare platforms, today released the PharmEasy Health Report 2025, an annual, data-led ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

What started as a clever chatbot that amazed the internet has quickly turned into one of the biggest, riskiest bets in modern ...

Amazon is positioned as a dominant AI infrastructure and monetization leader, with Q3 2025 net sales up 13%. Read why I am ...

Nvidia is a strong buy for 2026, with AI-driven growth and robust R&D set to boost its valuation. Click here to read my ...

The SPEED Act, sponsored by Rep. Bruce Westerman (R-Ark.), would update the 1969 National Environmental Policy Act, which many in the oil and gas industry blame for delays in ...